Harnessing the innate immune system to treat cancer: enhancement of antibody-dependent cellular cytotoxicity with anti-CD137 Ab

Posted On 2017-08-11 14:24:36

Atsushi Yonezawa1,2, Cariad Chester1,3, Narendiran Rajasekaran1, Holbrook E. Kohrt1

1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA; 2Department of Clinical Pharmacology & Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan; 3Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA

Contributions: (I) Conception and design: A Yonezawa, HE Kohrt; (II) Administrative support: HE Kohrt; (III) Provision of study materials or patients: A Yonezawa, C Chester, N Rajasekaran; (IV) Collection and assembly of data: A Yonezawa; (V) Data analysis and interpretation: C Chester, N Rajasekaran; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

Correspondence to: Holbrook E. Kohrt. Division of Oncology, Department of Medicine, Stanford University, CCSR Building, Room 1110, Stanford, CA 94305, USA. Email: kohrt@stanford.edu.

Read more>>